Related Experiment Video
Updated: Jun 8, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
Regenerative medicine: the emergence of an industry
1Parker H Petit Institute for Bioengineering and Bioscience, Georgia Tech/Emory Center for Regenerative Medicine, Georgia Institute of Technology, 315 Ferst Drive, NW, Atlanta, GA 30332-0363, USA. robert.nerem@ibb.gatech.edu
Abstract:
Over the last quarter of a century there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine. There have been 'ups and downs' in this industry; however, it now appears to be on a track that may be described as 'back to the future'. The latest data indicate that for 2007 the private sector activity in the world for this industry is approaching $2.5 billion, with 167 companies/business units and more than 6000 employee full time equivalents. Although small compared with the medical device and also the pharmaceutical industries, these numbers are not insignificant. Thus, there is the indication that this industry, and the related technology, may still achieve its potential and address the needs of millions of patients worldwide, in particular those with needs that currently are unmet.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...
Whole Body Regeneration
Mesenchymal Stem Cells
Stem Cell Culture
Induced Pluripotent Stem Cells

